Sign inJoin waitlistJoin the waitlist

Iyad Alnahhas

Division Chief, Neuro-Oncology · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY

Credentials: · · · · · ·

History

Neuro-Oncology Division · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present
SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present

Ohio State University Hospital
2017–2018
Neurology
Virginia Commonwealth University School of Medicine
2015–2017
Virginia Commonwealth University School of Medicine
2014–2015
Faculty of Medicine of Damascus University
2010–2014

Research

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
Review · Cancers · 2019 · 180 citations
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis
Review · Neuro-Oncology Advances · 2020 · First of 9 authors · Corresponding · 69 citations
Undergraduate medical students' perceptions, attitudes, and competencies in evidence-based medicine (EBM), and their understanding of EBM reality in Syria
BMC Research Notes · 2012 · 33 citations

WS
Wenyin Shi
12 papers
Pierre Giglio
10 papers
Vinay Puduvalli
10 papers
Appaji Rayi
6 papers · 6 as a fellow
Joshua Palmer
6 papers
SO
Shirley Ong
6 papers
Mehak Khan
5 papers · 3 as a resident
AK
Allison Kayne
4 papers · 3 as a resident
LC
Louis Cappelli
4 papers · 4 as a resident
AA
Ayesha Ali
3 papers · 3 as a resident
David Andrews
3 papers
Kevin Judy
3 papers

Clinical trials

Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)
Site PI · Recruiting · Phase 1
University of Utah
2025–2030
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Site PI · Recruiting · Phase 3
Nuvation Bio Inc.
2023–2030